Brainstorm Cell Therapeutics

View All

AstraZeneca announces; Trivitron launches; BrainStorm Cell Therapeutics validates

AstraZeneca announces availability of Saxa / Dapa FDC in UK UK-based AstraZeneca has announced the availability of Qtern for adult patients with type 2 diabetes in the country. Quern is a fixed dose combination of saxagliptin and dapagliflozin. The tablet received marketing authorization from the European Commission...

Find More

U.K. weighs drug rationing; Applying Digital; FDA slaps Florida

U.K. weighs drug rationing as NHS England's budget tightens: report Patients in the U.K. face yet another barrier to access as a tough budget situation has forced the country’s healthcare system to consider rationing costly drugs. Among them are medicines from Johnson & Johnson, Merck and Roche. Beginning in Apr...

Find More